2022 年基特森疟疾研讨会：从药物发现到治疗，对已取得的进展和未来的挑战进行了热烈讨论。
Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment.
机构信息
Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Laos.
出版信息
Trends Parasitol. 2022 Sep;38(9):711-718. doi: 10.1016/j.pt.2022.06.005. Epub 2022 Jul 18.
In recent years, the field of malaria research has made substantial progress in the areas of antimalarial drug resistance and discovery. These efforts are essential to combatting the devastating impact of malaria, which, in 2020, resulted in an estimated 241 million cases and 627 000 deaths. Recent advances in this area were presented at a Keystone Symposium entitled ‘Malaria: Confronting Challenges from Drug Discovery to Treatment’, held in person in Breckenridge, Colorado, in April 2022. Herein, we present a summary of the proceedings of this vibrant scientific exchange, which brought together a superb group of faculty, postdocs, and students from around the globe.
近年来，疟疾研究领域在抗疟药物耐药性和发现方面取得了重大进展。这些努力对于抗击疟疾的毁灭性影响至关重要，2020 年疟疾估计导致 2.41 亿例病例和 62.7 万人死亡。在 2022 年 4 月于科罗拉多州布雷肯里奇以现场方式举行的主题为“疟疾：从药物发现到治疗应对挑战”的 Keystone 研讨会上介绍了该领域的最新进展。在此，我们总结了这次充满活力的科学交流会议的情况，来自全球的杰出教师、博士后和学生参加了这次会议。
Zotero 插件